Anebulo Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020
Period Ending	Mar '26 Mar 6, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	2020
Market Capitalization	19	59	71	60	121	159	Upgrade
Market Cap Growth	-68.08%	-16.43%	17.53%	-50.38%	-23.75%	-	Upgrade
Enterprise Value	10	46	66	46	105	159	Upgrade
Last Close Price	0.46	1.44	2.73	2.35	5.20	6.82	Upgrade
PB Ratio	2.34	5.08	18.57	5.68	8.06	7.44	Upgrade
P/TBV Ratio	2.34	5.08	18.57	5.68	8.06	7.44	Upgrade
Net Debt / Equity Ratio	-1.14	-1.00	-0.81	-1.06	-0.97	-0.93	Upgrade
Quick Ratio	6.12	23.99	11.87	10.52	28.39	82.71	Upgrade
Current Ratio	6.24	24.53	13.46	10.92	30.40	89.61	Upgrade
Return on Equity (ROE)	-69.69%	-109.69%	-113.80%	-91.42%	-37.42%	-249.85%	Upgrade
Return on Assets (ROA)	-45.04%	-71.09%	-65.97%	-54.05%	-22.93%	-18.30%	Upgrade
Return on Capital Employed (ROCE)	-114.70%	-79.10%	-217.90%	-111.20%	-45.30%	-16.90%	Upgrade
Earnings Yield	-43.00%	-14.34%	-11.58%	-19.48%	-5.62%	-19.00%	Upgrade
Buyback Yield / Dilution	-55.97%	-30.97%	-2.98%	-7.41%	-71.49%	-13.44%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.